Literature DB >> 23079587

Global burden of cancer: opportunities for prevention.

Ahmedin Jemal1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23079587     DOI： 10.1016/S0140-6736(12)61688-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  26 in total

Review 1.  New Biomarkers for Selecting the Best Therapy Regimens in Metastatic Castration-Resistant Prostate Cancer.

Authors:  Isabel Heidegger; Axel Heidenreich; David Pfister
Journal:  Target Oncol       Date:  2017-02       Impact factor: 4.493

2.  TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy.

Authors:  Stephen L Shiao; Brian Ruffell; David G DeNardo; Bruce A Faddegon; Catherine C Park; Lisa M Coussens
Journal:  Cancer Immunol Res       Date:  2015-02-25       Impact factor: 11.151

3.  Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas.

Authors:  Asfar S Azmi; Ayad Al-Katib; Amro Aboukameel; Dilara McCauley; Michael Kauffman; Sharon Shacham; Ramzi M Mohammad
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

4.  Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.

Authors:  Brenda K Edwards; Anne-Michelle Noone; Angela B Mariotto; Edgar P Simard; Francis P Boscoe; S Jane Henley; Ahmedin Jemal; Hyunsoon Cho; Robert N Anderson; Betsy A Kohler; Christie R Eheman; Elizabeth M Ward
Journal:  Cancer       Date:  2013-12-16       Impact factor: 6.860

5.  Caspase-8 polymorphisms and risk of oral squamous cell carcinoma.

Authors:  Y I Tang; Yang Liu; Wei Zhao; Tao Yu; Haiyang Yu
Journal:  Exp Ther Med       Date:  2015-10-26       Impact factor: 2.447

6.  Pancreatic cancer: Current status and Challenges.

Authors:  Amanda R Muñoz; Divya Chakravarthy; Jingjing Gong; Glenn A Halff; Rita Ghosh; Addanki P Kumar
Journal:  Curr Pharmacol Rep       Date:  2017-10-11

7.  Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.

Authors:  Manish Kumar; Ajay Matta; Olena Masui; Gunjan Srivastava; Jatinder Kaur; Alok Thakar; Nootan Kumar Shukla; Ajoy RoyChoudhury; Meherchand Sharma; Paul G Walfish; K W Michael Siu; Shyam Singh Chauhan; Ranju Ralhan
Journal:  J Transl Med       Date:  2015-08-30       Impact factor: 5.531

8.  Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer.

Authors:  T V Macfarlane; K Lefevre; M C Watson
Journal:  Br J Cancer       Date:  2014-09-11       Impact factor: 7.640

9.  Correlation between superoxide dismutase 1 and 2 polymorphisms and susceptibility to oral squamous cell carcinoma.

Authors:  Ying Liu; Lagabaiyila Zha; Bo Li; Louqiang Zhang; Tao Yu; Longjiang Li
Journal:  Exp Ther Med       Date:  2013-10-31       Impact factor: 2.447

10.  Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer.

Authors:  Catia Moutinho; Anna Martinez-Cardús; Cristina Santos; Valentin Navarro-Pérez; Eva Martínez-Balibrea; Eva Musulen; F Javier Carmona; Andrea Sartore-Bianchi; Andrea Cassingena; Salvatore Siena; Elena Elez; Josep Tabernero; Ramon Salazar; Albert Abad; Manel Esteller
Journal:  J Natl Cancer Inst       Date:  2013-11-22       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.